https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2910/phase-ii-randomized-open-label/?qd=66078893
A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination with...
New life-saving treatments for Prostate in clinical trial on A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination...
https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2910/phase-ii-randomized-open-label/?qd=66244485
A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination with...
New life-saving treatments for Prostate in clinical trial on A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination...
https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2870/phase-ii-randomized-open-label/
A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination with...
New life-saving treatments for Prostate in clinical trial on A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination...
https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2870/phase-ii-randomized-open-label/?qd=65762668
A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination with...
New life-saving treatments for Prostate in clinical trial on A Phase II randomized open-label multi-center study of JSB462 (luxdegalutamide) in combination...